Domenico Di Giorgio, Giuseppe Scrofina, B. Scognamiglio, N. Di Carluccio, Romina Tulimiero, Adriano Pietrosanto, P. Petrone, Mila De Iure, Maria Grazia Chimenti, E. Pozzetti, Maurizio Giacomazzi, R. Berno, M. Lupo, M. Giaccone, M. Pani, Emanuele Cesta, Oscar Cruciani, C. Maione, M. Gramazio, Gianpaolo Derossi
{"title":"Tackling distribution-related shortages of medicines: An Italian case study evaluated in the European Union framework","authors":"Domenico Di Giorgio, Giuseppe Scrofina, B. Scognamiglio, N. Di Carluccio, Romina Tulimiero, Adriano Pietrosanto, P. Petrone, Mila De Iure, Maria Grazia Chimenti, E. Pozzetti, Maurizio Giacomazzi, R. Berno, M. Lupo, M. Giaccone, M. Pani, Emanuele Cesta, Oscar Cruciani, C. Maione, M. Gramazio, Gianpaolo Derossi","doi":"10.1177/2399202619856859","DOIUrl":null,"url":null,"abstract":"Availability of human medicines is affected by problems associated with both manufacturing and distribution-related issues. The lack of definition of “shortages” or “unavailability” of medicines in European regulation represents an obstacle to the set up of proper preventive and counteracting measures. In this review, we describe how, within this framework, Italy started a program of shared activities, involving central and local authorities, police forces, and private stakeholders’ associations through an “ad hoc technical forum,” that reduced the extent of the problem, at least in the short term, as demonstrated through some indicators defined by considering the key medicines affected by unavailability due to distribution-related issues. These measures should be strengthened and complemented with others so as to ensure their effectiveness in the long term.","PeriodicalId":74158,"journal":{"name":"Medicine access @ point of care","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2399202619856859","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine access @ point of care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2399202619856859","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Availability of human medicines is affected by problems associated with both manufacturing and distribution-related issues. The lack of definition of “shortages” or “unavailability” of medicines in European regulation represents an obstacle to the set up of proper preventive and counteracting measures. In this review, we describe how, within this framework, Italy started a program of shared activities, involving central and local authorities, police forces, and private stakeholders’ associations through an “ad hoc technical forum,” that reduced the extent of the problem, at least in the short term, as demonstrated through some indicators defined by considering the key medicines affected by unavailability due to distribution-related issues. These measures should be strengthened and complemented with others so as to ensure their effectiveness in the long term.